VENTRIX
Ventrix Inc. was founded in 2009 to spinout the research of Professor Karen Christman (Bioengineering) and her graduate students (Jen Singelyn, Jessica DeQuach, Michael Salvatore). The technology license agreement was formalized in FY2011. Dr. Christman’s work has developed promising results for the treatment and repair of cardiac tissue damage. A departure from current approaches, this innovation is a hydrogel that treats damaged tissue by providing a restorative scaffold on which new cells c... an grow. This hydrogel, VentriGel, is made from cardiac connective tissue that is stripped of heart muscle cells through a cleansing process, freeze-dried and milled into powder form, and then liquefied into a fluid that can be easily injected into the heart. Upon reaching body temperature, the liquid turns into a semi-solid, porous gel that encourages cells to repopulate areas of damaged cardiac tissue and to preserve heart function. The hydrogel forms a scaffold to repair the tissue and possibly provides biochemical signals that prevent further deterioration in the surrounding tissues.
VENTRIX
Industry:
Biotechnology Health Care Medical
Founded:
2009-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.ventrixbio.com
Total Employee:
11+
Status:
Active
Contact:
6197860350
Email Addresses:
[email protected]
Total Funding:
5.31 M USD
Technology used in webpage:
Google Apps For Business Squarespace Hosted NSONE Google Postini Services
Similar Organizations
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Illumina
Illumina is an innovative technology and revolutionary assays aiming the analyze genetic variation and function.
Impact Biomedicines
Impact Biomedicines is pioneering the development of life-changing treatments for patients.
Pathway Genomics
Pathway Genomics is a CAP accredited global clinical lab offering genetic tests for cancer risk, drug responses, and other conditions.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Vital Therapies
Vital Therapies is a biotech company focused on developing a cell-based therapy targeting the treatment of acute liver failure.
Current Employees Featured
Founder
Official Site Inspections
http://www.ventrixbio.com Semrush global rank: 10.6 M Semrush visits lastest month: 214
- Host name: 198.49.23.145
- IP address: 198.49.23.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Ventrix"
Ventrix Bio
Ventrix is focused on creating a new class of biotherapeutics that offer the benefits of native ECM to guide your body to repair and generate new healthy microenvironment and tissue.See details»
About Us — Ventrix
Dr. Christman co-founded Ventrix in 2009 and guided the initial scientific research to develop VentriGel from benchside to a translatable clinical therapy. Christman is a Professor in the …See details»
Contact — Ventrix
Our Office. 3030 Bunker Hill Street Suite 117D San Diego, CA, 92109 United StatesSee details»
Ventrix - Crunchbase Company Profile & Funding
Ventrix delivers a biomaterial scaffold for cardiac repair as a treatment option for cardiac patients. View contacts for Ventrix to access new leads and connect with decision-makers.See details»
Ventrix - BIO International Convention 2024
Jun 4, 2024 · Ventrix is a clinical-stage company developing a new class of injectable biotherapeutics to treat heart disease and other conditions. Ventrix’s technology is centered …See details»
Ventrix - Products, Competitors, Financials, Employees, …
Ventrix is a leader in extracellular matrix (ECM) biotherapeutics within the biotechnology sector. The company specializes in developing a new class of biotherapeutics that utilize the …See details»
Ventrix | VentureRadar
Website: https://ventrixbio.com/ Develops innovative biotherapeutics utilizing native extracellular matrix to promote tissue repair and regeneration by supporting proper cell behavior and …See details»
Ventrix, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Sep 19, 2024 · VentriGel was delivered in 15 patients with moderate LV dysfunction (25% ≤ LV ejection fraction ≤ 45%) who were between 60 days to 3 years post-MI and were …See details»
Ventrix - Biotechnology - Overview, Competitors, and Employees
View Ventrix (http://www.ventrixbio.com) location in California, United States, revenue, competitors and contact information. Find and reach Ventrix's employees by department, …See details»
Ventrix Profile - highergov.com
Ventrix (UEI GZK6V6LL3SM8, CAGE 5DP40) based in Carlsbad CA federal contracts, grants, registrations, vehicles, partnerships, and analysisSee details»
Ventrix Company Profile - Office Locations, Competitors ... - Craft
Ventrix is a clinical-stage company engaged in regenerative medicine and tissue engineering. It is focused on delivering a biomaterial scaffold for cardiac repair for heart attack patients. Ventrix …See details»
Science — Ventrix
Ventrix is focused on engineering a new porous and fibrous scaffold where ECM has been degraded, thus generating a new healthy microenvironment to facilitate repair. Cardiovascular …See details»
Ventrix, Inc. (Ventrix, Inc.) - 药物管线_专利_临床试验_投融营收
VentriGel was delivered in 15 patients with moderate LV dysfunction (25% ≤ LV ejection fraction ≤ 45%) who were between 60 days to 3 years post-MI and were revascularized by percutaneous …See details»
Intravascularly infused extracellular matrix as a biomaterial for ...
Dec 29, 2022 · Here we report the safety and feasibility of an intravascularly infused extracellular matrix as a biomaterial for the repair of tissue in animal models of acute myocardial infarction, …See details»
Infusible extracellular matrix - Nature
Christman and team, along with Ventrix Bio, Inc., are now planning investigational new drug (IND)-enabling studies for the myocardial infarction application.See details»
Product — Ventrix
Our goal for developing tissue engineering scaffolds is to mimic the in vivo extracellular matrix (ECM) for a particular tissue, providing a scaffold environment for cell-matrix interactions. …See details»
Working at Ventrix Health Innovation - Glassdoor
See what employees say it's like to work at Ventrix Health Innovation. Salaries, reviews, and more - all posted by employees working at Ventrix Health Innovation.See details»
What is a matrix organization and how does it work? - Asana
Feb 22, 2024 · What is a matrix organization and how does it work? A matrix organization is a company structure where teams report to multiple leaders. The matrix design keeps open …See details»
Ventrix Initiates Clinical Trial of VentriGel™ — Ventrix
Feb 27, 2017 · Ventrix, Inc., today announced that it has initiated a Phase 1 trial of VentriGel™, an off-the-shelf, biomaterial scaffold designed to facilitate the repair of cardiac tissue following …See details»
Press Releases - Ventrix
Ventrix, Inc. announced today that its VentriGel cardiac repair scaffold safely and effectively mitigated left ventricular remodeling and improved cardiac function in pigs after myocardial …See details»